ARCHIVES

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

Panel Recommends 5-FU/Levamisole For Adjuvant Stage 3 Colon Cancer

April 27, 1990

Virus Cancer Program Report On Scientific Activities

August 1, 1975

Weinstein Applauds Investigation Report

September 26, 1997

In Brief: Eppley Is The “New” Center Getting an NCI Core; USC Appoints Jones Basic Science Chief

May 4, 1984

In Brief: Coltman, Leb Lead ASCO, AACR; Young, Busch Presidents Elect; Renalda Hilkemeyer Honored

June 3, 1988

SEC Investigating Bristol-Myers’ Sales Statements

July 12, 2002